PUBLISH YOUR EVENTS!
Boston Professional Events List
Diabetes Summit (GTC)
Date
Organizer
Location
Diabetes Summit
GTCbio and the advisory board would like to invite you to the 11th Diabetes Summit to be held April 10-11, 2021 in Boston, MA. GTCbio’s Diabetes Summit encompasses the drug discovery and partnering aspects of diabetes in three tracks.. Experts from industry and academia will discuss strategies to target Type 1 and Type 2 diabetes in presentations, panels and round-table discussions that highlight basic research novel therapeutic targets, translation to the clinic, devices and digital aids, funding and partnering trends, emerging technologies and other relevant topics.
Joint Plenary Sessions:
-
Opening Keynote Session – Historical Perspective & Current State of the Industry
-
Round Table Discussions
-
Ready, Set, Grow – New Company/Technology Pitch Competition & Lunch
-
Award Ceremony & Closing Keynote Session – Predictions for future
Track 1: Diabetes Drug Discovery & Development Conference
-
What’s New in Type I Diabetes – Targets, Models, Assays, etc.
-
Translational and Clinical Development for Type I Diabetes
-
What’s New in Type II Diabetes – Targets, Models, Assays, etc.
-
Translational and Clinical Development for Type II Diabetes
Track 2: Diabetes Partnering & Deal-Making Conference
-
Industry Partnering with Academia and CROs to Advance Research
-
Investments from Private, Institutional and Public Sources
Track 3: Devices and Digital Aids in Diabetes Management Conference
-
Next Generation Glucose Monitoring Devices and Technology
-
The Role of “Being Digitally Connected” in Diabetes Management
AGENDA
Day 1 – Monday, April 9, 2021
4:00 pm Registration Open
5:00 pm Opening Remarks by Dr. Satish Medicetty
5:10 pm Program Preview by Alan Cherrington
5:30 pm Focus Group Discussions – Part I (Challenges and Opportunities)
7:00 pm End of Day 1
Day 2 – Tuesday, April 10, 2021
Drug Discovery & Development for Diabetes
7:15 am Continental Breakfast & Registration
7:15 am Breakfast with Mentors from Academia & Industry (RSVP Only)
8:30 am
Opening Keynote Session: Historical Perspective and State of the Industry
9:50 am Morning Networking Break
10:30 am Type I Diabetes – Preclinical and Clinical Development Drug
12:35 pm Lunch and Short-talks from poster presenters
2:00 pm Type II Diabetes – Preclinical and Clinical Development
4:05 pm Afternoon Networking Break
4:30 pm
Devices and Digital Aids in Diabetes Management
5:30 pm Networking Reception & Poster Session
Day 3 – Wednesday, April 11, 2021
Funding, Partnering and Commercialization of Diabetes Technologies
7:00 am Continental Breakfast for All Attendees
7:15 am Focus Group Discussions – Part I (Challenges and Opportunities)
8:30 am I. Industry Partnering with Academia & CROs to Advance Diabetes Research
10:10 am Morning Networking Break
10:40 am II. Funding & Commercialization of Diabetes Technologies
12:20 pm Lunch Provided by GTCbio | New Company/Technology Showcase (5 companies with 10 minutes each)
1:30 pm Award Ceremony & Closing Keynote Session – Predictions for the Future
2:10 pm Keynote Panel Discussion
3:00 pm
Conference Concludes
SPEAKER
Domenico Accili
Professor of Medicine
Columbia University
Nir Barzilai
Professor, Department of Medicine (Endocrinology); Professor, Department of Genetics
Albert Einstein College of Medicine
Brian Bloomquist
Senior Director, Global External Research and Development
Eli Lilly
Andrew Young
Vice President, Chief Scientific Officer
Intarcia
DISTINGUISHED SPEAKERS
Julia Babensee
Associate Professor
Georgia Tech
William Bachovchin
Professor, Department of Biochemistry
Tufts University School of Medicine
Jonathan Behr
Managing Director
JDRF
Michael Brehm
Associate Professor
University of Massachusetts Medical School
Alan Cherrington
Professor of Molecular Physiology and Biophysics
Vanderbilt University
Joseph Cook
President and Executive Chairman of the Board
Nusirt Inc.
Denise Faustman
Director of Immunobiology; Associate Professor of Medicine
Massachusetts General Hospital; Harvard Medical School
Alexander (Zan) Fleming
Executive Chairman
Kinexum
Robert Geho
Co-Founder and Chief Executive Officer
Diasome Pharmaceuticals Inc
Judith Gorski
Global Director, Scientific Engagement
Crown Bioscience Inc.
Julia Greenstein
Vice President, Research Strategy
JDRF
Wende Hutton
General Partner
Canaan
Scott Johnson
Communications Lead
mySugr GmbH
Vijay Koya
Senior Scientist
Boston Scientific
Martin Lafontaine
Commercialization Consultant
Kinexum
David Maggs
Chief Medical Officer
Fractyl Laboratories
Felicia Pagliuca
Vice President, Cell Biology R&D
Semma Therapeutics
Steven Russell
Assistant Professor of Medicine
Harvard Medical School
Aaron Schwartz
Director, R&D Innovation Sourcing
Novo Nordisk Inc.
Donald Scott
Professor in the Division of Endocrinology, Diabetes and Bone Disease
Icahn School of Medicine at Mount Sinai
Thomas Seoh
Chief Executive Officer
Kinexum
Maria Trujillo
Principal Scientist, Quantitative Pharmacology and Pharmacometrics
Merck & Co.
Michael Zemel
Founder and Chief Scientific Officer
Nusirt Inc.
"Please contact the event manager Marilyn (marilyn.b.turner(at)nyeventslist.com ) below for:
- Multiple participant discounts
- Price quotations or visa invitation letters
- Payment by alternate channels (PayPal, check, Western Union, wire transfers etc)
- Event sponsorship
NO REFUNDS ALLOWED ON REGISTRATIONS
Prices may go up any time. Service fees included in pricing.
-----------------------------------------------------------------
This event is brought to you by:
Global Technology Community LLC - NewYorkEventsList
http://www.NyEventsList.com
http://www.BostonEventsList.com
http://www.SFBayEventsList.com
-----------------------------------------------------------------
MYL171011CEV CHA171109UPT MAR20211124REV
VIO180227UPD MYL180302UPD JOA180315CEV